X
VBIV

Xponance’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Xponance’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-357
Closed -$3.25K – 1310
2023
Q1 		$3.25K Hold
357
– – ﹤0.01% 1240
2022
Q4 		$4.19K Buy
357
+3
+0.8% +$53 ﹤0.01% 1232
2022
Q3 		$8K Buy
354
+9
+3% +$243 ﹤0.01% 1190
2022
Q2 		$8K Buy
+345
New +$11.7K ﹤0.01% 1190
2021
Q3 		– Sell
-340
Closed -$34K – 1244
2021
Q2 		$34K Buy
+340
New +$33.1K ﹤0.01% 1235

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return